Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (308) Arrow Down
Filter Results: (308) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (308)
    • News  (99)
    • Research  (172)
  • Faculty Publications  (74)

Show Results For

  • All HBS Web  (308)
    • News  (99)
    • Research  (172)
  • Faculty Publications  (74)
← Page 3 of 308 Results →
  • October 2003 (Revised February 2010)
  • Case

The Duke Heart Failure Program

By: Richard M.J. Bohmer and Laura Feldman
Duke University Health System has for the past five years operated a specialized clinic for the management of congestive heart failure, a very common and costly condition in the surrounding community. Nurse practitioners, whose work is guided by highly specified... View Details
Keywords: Health Care and Treatment; Health Disorders; Medical Specialties; Time Management; Service Delivery; Service Operations; Outcome or Result; Health Industry
Citation
Educators
Purchase
Related
Bohmer, Richard M.J., and Laura Feldman. "The Duke Heart Failure Program." Harvard Business School Case 604-033, October 2003. (Revised February 2010.)
  • November 2001 (Revised September 2004)
  • Case

Evolution of Treatment, The: The Case of Diabetes

By: Richard M.J. Bohmer, Jeffrey D. Street and Laura Feldman
Scientific knowledge surrounding diabetes mellitus has grown over the last century to include its cause, treatment, and prevention strategies. However, the type and level of care that patients receive is suboptional. This case examines the forces in industry,... View Details
Keywords: Policy; Health Care and Treatment; Innovation and Management; Knowledge Use and Leverage; Management; Management Analysis, Tools, and Techniques; Health Industry
Citation
Educators
Purchase
Related
Bohmer, Richard M.J., Jeffrey D. Street, and Laura Feldman. "Evolution of Treatment, The: The Case of Diabetes." Harvard Business School Case 302-023, November 2001. (Revised September 2004.)
  • 25 Nov 2011
  • News

The history of Black Friday

  • February 2000
  • Case

E2M Health Services

By: Richard M.J. Bohmer and Naomi Atkins
Outlines the growth of an innovative diabetes disease management organization from 1994-99. Having demonstrated the success of their model in managing diabetes populations in Texas and New York State, the CEO and president must decide the future strategy of the company... View Details
Keywords: Business Model; Customer Focus and Relationships; Decision Choices and Conditions; Financial Markets; Revenue; Innovation and Invention; Business or Company Management; Marketing Strategy; Internet; Health Industry
Citation
Educators
Purchase
Related
Bohmer, Richard M.J., and Naomi Atkins. "E2M Health Services." Harvard Business School Case 600-077, February 2000.
  • January 2023 (Revised September 2024)
  • Supplement

The END Fund (B)

By: V. Kasturi Rangan and Courtney Han
Founded in 2012, the END fund focused on eliminating five Neglected Tropical Diseases that accounted for 80% of the tropical diseases affecting nearly 1.5 billion people worldwide. Its roughly $25 million/year annual budget was fully committed when it got news that the... View Details
Keywords: Health Disorders; Investment Funds; Global Range; Nonprofit Organizations; Resource Allocation; Decisions; Health Care and Treatment; Mission and Purpose
Citation
Purchase
Related
Rangan, V. Kasturi, and Courtney Han. "The END Fund (B)." Harvard Business School Supplement 523-064, January 2023. (Revised September 2024.)

    Jason T. Pananos

    Jason Pananos is a Senior Lecturer of Business Administration in the Finance Department.  Jason currently teaches and was the co-creator of a second-year field course titled “Value Creation in Small and Medium Firms”.  Jason is also an active collaborator and guest... View Details

    • August 2009 (Revised April 2012)
    • Case

    Genzyme's CSR Dilemma: How to Play its HAND

    By: Christopher A. Bartlett, Tarun Khanna and Prithwiraj Choudhury
    Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details
    Keywords: Global Strategy; Health Care and Treatment; Intellectual Property; Corporate Social Responsibility and Impact; Partners and Partnerships; Research and Development; Biotechnology Industry
    Citation
    Educators
    Purchase
    Related
    Bartlett, Christopher A., Tarun Khanna, and Prithwiraj Choudhury. "Genzyme's CSR Dilemma: How to Play its HAND." Harvard Business School Case 910-407, August 2009. (Revised April 2012.)
    • June 2006 (Revised June 2007)
    • Background Note

    The Challenge Facing the U.S. Healthcare Delivery System

    By: Richard M.J. Bohmer and Carin-Isabel Knoop
    Discusses the challenges currently facing the U.S. health care delivery system. These challenges frame the problems managers of delivery organizations are currently facing. They include a burgeoning gap between demand and supply. Demand for health care services is... View Details
    Keywords: Health Care and Treatment; Health Industry; United States
    Citation
    Educators
    Purchase
    Related
    Bohmer, Richard M.J., and Carin-Isabel Knoop. "The Challenge Facing the U.S. Healthcare Delivery System." Harvard Business School Background Note 606-096, June 2006. (Revised June 2007.)
    • January – February 2008
    • Article

    The Dangers of Wishful Thinking

    By: Richard S. Tedlow and David Ruben
    Too many U.S. businesses (including tires, super-markets, and information technology) have been infected with the disease of denial. The answer? In Lincoln's words, “We must disenthrall ourselves.” View Details
    Keywords: Knowledge Acquisition; Knowledge Use and Leverage; Leadership; Growth and Development Strategy; Success; Behavior; Cognition and Thinking
    Citation
    Find at Harvard
    Related
    Tedlow, Richard S., and David Ruben. "The Dangers of Wishful Thinking." The American: A Magazine of Ideas (January–February 2008).
    • 09 Apr 2015
    • News

    Ariad Pharmaceuticals’ chief fights to hold on

    • 30 Jan 2020
    • News

    What Organizations Need to Survive a Pandemic

    • 21 Nov 2005
    • Research & Ideas

    The Geography of Corporate Giving

    Academy of Management Review, HBS professor Christopher Marquis and coauthors Gerald Davis and Mary Ann Glynn develop a framework for understanding an important aspect of this issue: how social and governmental forces in local communities... View Details
    Keywords: by Sean Silverthorne
    • February 2011 (Revised November 2012)
    • Case

    PatientsLikeMe: An Online Community of Patients

    By: Sunil Gupta and Jason Riis
    PatientsLikeMe (PLM) is an online community where patients share their personal experiences with a disease, find other patients like them, and learn from each other. The company was founded by Jamie and Ben Heywood when their 29-year-old brother was diagnosed with ALS... View Details
    Keywords: Business Startups; Health Disorders; Knowledge Sharing; Growth and Development Strategy; Product Launch; Digital Platforms; Social and Collaborative Networks; Health Industry
    Citation
    Educators
    Purchase
    Related
    Gupta, Sunil, and Jason Riis. "PatientsLikeMe: An Online Community of Patients." Harvard Business School Case 511-093, February 2011. (Revised November 2012.)
    • September 8, 2020
    • Article

    Allocation of COVID-19 Relief Funding to Disproportionately Black Counties

    By: Pragya Kakani, Amitabh Chandra and Sendhil Mullainathan
    This study describes correlations between the dollar amount of relief funding authorized by the US Congress to fund prevention, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) and to reimburse health care entities for lost revenues, and county-level... View Details
    Keywords: COVID-19; Health Pandemics; Resource Allocation; Demographics; Race
    Citation
    Read Now
    Related
    Kakani, Pragya, Amitabh Chandra, and Sendhil Mullainathan. "Allocation of COVID-19 Relief Funding to Disproportionately Black Counties." JAMA, the Journal of the American Medical Association 324, no. 10 (September 8, 2020): 1000–1003.
    • Research Summary

    Overview of Research

    My research examines approaches to improving the performance of our health care delivery system with a primary focus on health information technology. Reflecting the interdisciplinary nature of my program, my dissertation draws upon theories and insights from... View Details

    • January 2018 (Revised January 2019)
    • Case

    ZappRx

    By: Jeffrey J. Bussgang and Olivia Hull
    In October 2015, ZappRx founder Zoe Barry is deciding between two business models for her health technology start-up. Her product, a software application that aims to expedite the prescription fulfillment process for patients with rare diseases, has attracted interest... View Details
    Keywords: Speciality Drugs; Hub Services; Pivot; Speciality Prescriptions; Health Care and Treatment; Customization and Personalization; Internet and the Web; Business Model; Decision Choices and Conditions; Pharmaceutical Industry; Massachusetts
    Citation
    Educators
    Purchase
    Related
    Bussgang, Jeffrey J., and Olivia Hull. "ZappRx." Harvard Business School Case 818-001, January 2018. (Revised January 2019.)
    • November 2009 (Revised January 2011)
    • Case

    International AIDS Vaccine Initiative

    By: Allen S. Grossman and Cathy Ross
    Dedicated to accelerating the development of a safe, effective, accessible, preventive HIV vaccine, the International AIDS Vaccine Initiative (IAVI) pioneered ways of addressing the inadequate incentive structures that prevented progress toward vaccines for AIDS and... View Details
    Keywords: Developing Countries and Economies; Globalized Firms and Management; Health Care and Treatment; Health Disorders; Business and Government Relations; Partners and Partnerships; Research and Development; Social Enterprise; Health Industry
    Citation
    Find at Harvard
    Related
    Grossman, Allen S., and Cathy Ross. "International AIDS Vaccine Initiative." Harvard Business School Case 310-015, November 2009. (Revised January 2011.)
    • Winter 2019
    • Article

    Value-based Health Care: Lessons for the Anesthesiologist

    By: J.A. Martin, B.L. Potter, T.F. Flanagan and T.W. Feeley
    At one point or another in our life, we all become consumers of the health care industry. Indeed, health care affects everyone and encompasses a diverse set of services from childbirth, to illness prevention, to the management of chronic disease and end-of-life care.... View Details
    Keywords: Value-based Health Care; Anesthesiologists; Health Care and Treatment; Value; Cost Management; Problems and Challenges; Health Industry; United States
    Citation
    Find at Harvard
    Register to Read
    Related
    Martin, J.A., B.L. Potter, T.F. Flanagan, and T.W. Feeley. "Value-based Health Care: Lessons for the Anesthesiologist." International Anesthesiology Clinics 57, no. 1 (Winter 2019): 63–80.
    • September–October 2020
    • Article

    The Past, Present, and (Near) Future of Gene Therapy and Gene Editing

    By: Julia Pian, Amitabh Chandra and Ariel Dora Stern
    Emerging gene therapy and gene-editing technologies will have a growing impact on patient lives and health-care delivery. We analyzed a decade of data on clinical trials and venture capital investments to understand the likely trajectory of genetically focused... View Details
    Keywords: Gene Therapy; Gene Editing; Impact; Health Care and Treatment; Technological Innovation; Health Testing and Trials; Venture Capital; Change
    Citation
    Find at Harvard
    Read Now
    Related
    Pian, Julia, Amitabh Chandra, and Ariel Dora Stern. "The Past, Present, and (Near) Future of Gene Therapy and Gene Editing." NEJM Catalyst Innovations in Care Delivery 1, no. 5 (September–October 2020).

      What Makes a Building Healthy?

      The pandemic spawned by the novel coronavirus has forced a global reckoning with the awesome power of infectious diseases to grind economies to a halt. The forced lockdowns and retreat into home isolation has also given us a heightened awareness of the role our... View Details
      • ←
      • 3
      • 4
      • …
      • 15
      • 16
      • →
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.